(COVH) Covivio Hotels - Ratings and Ratios
Hotels,Resorts,Accommodation
Description: COVH Covivio Hotels
Covivio Hotels is a French real estate investment trust (REIT) specializing in hotels and resorts, listed on the Paris stock exchange under the ticker symbol COVH. The companys market capitalization stands at approximately €3.74 billion, indicating a significant presence in the European real estate sector.
With a Price-to-Earnings (P/E) ratio of 17.17, Covivio Hotels is valued relatively in line with industry peers, suggesting a moderate growth expectation. The Return on Equity (RoE) of 7.78% indicates a decent level of profitability, although this metric should be evaluated in the context of the overall industry and market conditions.
The hotel industry is closely tied to macroeconomic factors such as GDP growth, tourism trends, and consumer spending. As a REIT, Covivio Hotels performance is also influenced by factors like interest rates, property valuations, and rental income. Key Performance Indicators (KPIs) to watch for Covivio Hotels include occupancy rates, average daily rates (ADR), and revenue per available room (RevPAR), which are crucial in assessing the operational performance of its hotel portfolio.
The companys financial health and ability to generate cash flows will be critical in navigating the cyclical nature of the hotel industry. Investors should monitor metrics like debt-to-equity ratio, interest coverage ratio, and cash flow from operations to gauge Covivio Hotels financial resilience and capacity to invest in growth opportunities or weather economic downturns.
In the broader economic context, Covivio Hotels is exposed to trends in European tourism, economic growth, and the competitive landscape of the hotel industry. The rise of alternative accommodation platforms and changing consumer preferences may also impact the companys strategy and performance. A thorough analysis of these factors is essential to understanding the investment potential of Covivio Hotels.
COVH Stock Overview
Market Cap in USD | 4,288m |
Sub-Industry | Hotel & Resort REITs |
IPO / Inception |
COVH Stock Ratings
Growth Rating | 86.7% |
Fundamental | 58.9% |
Dividend Rating | 71.7% |
Return 12m vs S&P 500 | 17.1% |
Analyst Rating | - |
COVH Dividends
Dividend Yield 12m | 7.01% |
Yield on Cost 5y | 13.94% |
Annual Growth 5y | -3.26% |
Payout Consistency | 91.0% |
Payout Ratio | 111.1% |
COVH Growth Ratios
Growth Correlation 3m | 62.4% |
Growth Correlation 12m | 94.9% |
Growth Correlation 5y | 84.5% |
CAGR 5y | 16.31% |
CAGR/Max DD 5y | 0.68 |
Sharpe Ratio 12m | -0.18 |
Alpha | 34.00 |
Beta | -0.243 |
Volatility | 15.56% |
Current Volume | 0.2k |
Average Volume 20d | 0.2k |
Stop Loss | 22.5 (-3%) |
Signal | 1.50 |
Piotroski VR‑10 (Strict, 0-10) 3.5
Net Income (264.6m TTM) > 0 and > 6% of Revenue (6% = 55.1m TTM) |
FCFTA 0.06 (>2.0%) and ΔFCFTA 3.70pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 4.88% (prev 5.04%; Δ -0.16pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.08 (>3.0%) and CFO 570.8m > Net Income 264.6m (YES >=105%, WARN >=100%) |
Net Debt (2.50b) to EBITDA (469.5m) ratio: 5.33 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.06 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (148.1m) change vs 12m ago NaN% (target <= -2.0% for YES) |
Gross Margin 47.46% (prev 53.39%; Δ -5.93pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 13.23% (prev 7.96%; Δ 5.27pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 2.73 (EBITDA TTM 469.5m / Interest Expense TTM 142.1m) >= 6 (WARN >= 3) |
Altman Z'' 0.76
(A) 0.01 = (Total Current Assets 801.3m - Total Current Liabilities 756.5m) / Total Assets 7.16b |
(B) 0.03 = Retained Earnings (Balance) 224.6m / Total Assets 7.16b |
(C) 0.06 = EBIT TTM 388.2m / Avg Total Assets 6.94b |
(D) 0.23 = Book Value of Equity 817.2m / Total Liabilities 3.55b |
Total Rating: 0.76 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.85
1. Piotroski 3.50pt = -1.50 |
2. FCF Yield 6.51% = 3.26 |
3. FCF Margin 43.32% = 7.50 |
4. Debt/Equity 0.81 = 2.18 |
5. Debt/Ebitda 5.93 = -2.50 |
6. ROIC - WACC 2.03% = 2.53 |
7. RoE 7.78% = 0.65 |
8. Rev. Trend -6.18% = -0.31 |
9. Rev. CAGR 0.0% = 0.0 |
10. EPS Trend -18.23% = -0.46 |
11. EPS CAGR -34.53% = -2.50 |
What is the price of COVH shares?
Over the past week, the price has changed by -1.69%, over one month by -2.52%, over three months by +4.98% and over the past year by +36.95%.
Is Covivio Hotels a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of COVH is around 27.09 EUR . This means that COVH is currently undervalued and has a potential upside of +16.77% (Margin of Safety).
Is COVH a buy, sell or hold?
What are the forecasts/targets for the COVH price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 18.3 | -21.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 28.9 | 24.5% |
COVH Fundamental Data Overview
Market Cap EUR = 3.68b (3.68b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 358.6m EUR (last quarter)
P/E Trailing = 16.6667
P/S = 9.772
P/B = 1.0386
Beta = 0.881
Revenue TTM = 918.0m EUR
EBIT TTM = 388.2m EUR
EBITDA TTM = 469.5m EUR
Long Term Debt = 2.24b EUR (from longTermDebt, last quarter)
Short Term Debt = 542.6m EUR (from shortTermDebt, last quarter)
Debt = 2.79b EUR (Calculated: Short Term 542.6m + Long Term 2.24b)
Net Debt = 2.50b EUR (from netDebt column, last quarter)
Enterprise Value = 6.11b EUR (3.68b + Debt 2.79b - CCE 358.6m)
Interest Coverage Ratio = 2.73 (Ebit TTM 388.2m / Interest Expense TTM 142.1m)
FCF Yield = 6.51% (FCF TTM 397.7m / Enterprise Value 6.11b)
FCF Margin = 43.32% (FCF TTM 397.7m / Revenue TTM 918.0m)
Net Margin = 28.82% (Net Income TTM 264.6m / Revenue TTM 918.0m)
Gross Margin = 47.46% ((Revenue TTM 918.0m - Cost of Revenue TTM 482.3m) / Revenue TTM)
Tobins Q-Ratio = 7.48 (Enterprise Value 6.11b / Book Value Of Equity 817.2m)
Interest Expense / Debt = 1.83% (Interest Expense 51.0m / Debt 2.79b)
Taxrate = 11.41% (from yearly Income Tax Expense: 30.5m / 267.2m)
NOPAT = 343.9m (EBIT 388.2m * (1 - 11.41%))
Current Ratio = 1.06 (Total Current Assets 801.3m / Total Current Liabilities 756.5m)
Debt / Equity = 0.81 (Debt 2.79b / last Quarter total Stockholder Equity 3.43b)
Debt / EBITDA = 5.93 (Net Debt 2.50b / EBITDA 469.5m)
Debt / FCF = 7.01 (Debt 2.79b / FCF TTM 397.7m)
Total Stockholder Equity = 3.40b (last 4 quarters mean)
RoA = 3.70% (Net Income 264.6m, Total Assets 7.16b )
RoE = 7.78% (Net Income TTM 264.6m / Total Stockholder Equity 3.40b)
RoCE = 6.88% (Ebit 388.2m / (Equity 3.40b + L.T.Debt 2.24b))
RoIC = 5.64% (NOPAT 343.9m / Invested Capital 6.10b)
WACC = 3.61% (E(3.68b)/V(6.47b) * Re(5.12%)) + (D(2.79b)/V(6.47b) * Rd(1.83%) * (1-Tc(0.11)))
Shares Correlation 5-Years: 80.0 | Cagr: 2.56%
Discount Rate = 5.12% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 71.65% ; FCFE base≈288.5m ; Y1≈199.8m ; Y5≈101.6m
Fair Price DCF = 12.44 (DCF Value 1.96b / Shares Outstanding 158.0m; 5y FCF grow -36.03% → 3.0% )
Revenue Correlation: -6.18 | Revenue CAGR: 0.0%
Rev Growth-of-Growth: -162.5
EPS Correlation: -18.23 | EPS CAGR: -34.53%
EPS Growth-of-Growth: 431.4